Remed Co.Ltd - Asset Resilience Ratio

Latest as of March 2026: 4.13%

Remed Co.Ltd (302550) has an Asset Resilience Ratio of 4.13% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩2.26 Billion

≈ $1.53 Million USD Cash + Short-term Investments

Total Assets

₩54.74 Billion

≈ $37.10 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Remed Co.Ltd's Asset Resilience Ratio has changed over time. Check Remed Co.Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Remed Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 302550 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩2.26 Billion	4.13%
Total Liquid Assets	₩2.26 Billion	4.13%

Asset Resilience Insights

Limited Liquidity: Remed Co.Ltd maintains only 4.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Remed Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Remed Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Remed Co.Ltd (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Remed Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	8.46%	₩4.56 Billion ≈ $3.09 Million	₩53.91 Billion ≈ $36.53 Million	-9.62pp
2024-12-31	18.08%	₩10.68 Billion ≈ $7.24 Million	₩59.06 Billion ≈ $40.03 Million	+10.19pp
2023-12-31	7.89%	₩4.35 Billion ≈ $2.95 Million	₩55.06 Billion ≈ $37.31 Million	-31.31pp
2022-12-31	39.20%	₩30.63 Billion ≈ $20.76 Million	₩78.13 Billion ≈ $52.94 Million	-7.97pp
2021-12-31	47.17%	₩36.42 Billion ≈ $24.68 Million	₩77.20 Billion ≈ $52.32 Million	-9.50pp
2020-12-31	56.67%	₩41.64 Billion ≈ $28.22 Million	₩73.47 Billion ≈ $49.79 Million	+13.13pp
2019-12-31	43.54%	₩15.22 Billion ≈ $10.31 Million	₩34.95 Billion ≈ $23.68 Million	+14.33pp
2018-12-31	29.21%	₩6.28 Billion ≈ $4.26 Million	₩21.51 Billion ≈ $14.58 Million	+6.47pp
2017-12-31	22.74%	₩2.86 Billion ≈ $1.94 Million	₩12.59 Billion ≈ $8.53 Million	--

pp = percentage points

About Remed Co.Ltd

KQ:302550 Korea Medical Devices

Market Cap

$54.78 Million

₩80.83 Billion KRW

Market Cap Rank

#21497 Global

#1239 in Korea

Share Price

₩2670.00

Change (1 day)

+2.50%

52-Week Range

₩2485.00 - ₩3985.00

All Time High

₩4180.00